Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia
The Oncologist · 06.06.2026 · 31 (7)
DOI: 10.1093/oncolo/oyag237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 18.06.2026. Verfasst von Bikila Lencha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, School of Health Sciences, Madda Walabu University, Shashemene, Oromia, Ethiopia. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, HIV Infections, Early Detection of Cancer. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Women living with human immunodeficiency virus face a heightened risk of cervical cancer. Lack of follow-up rescreening among women with cervical lesions could result in increased risk of cancer-related morbidity and mortality.
Methods
A retrospective cross-sectional study was conducted among 191 women living with HIV who tested positive for visual inspection with acetic acid and were treated from September 2020 to September 2023. A data extraction checklist was used to collect data from October 1, 2023 to March 30, 2024. Descriptive statistics was computed and then logistic regression analysis was used to assess the association between the independent variables and follow-up rescreening. The association was ascertained using adjusted odds ratio (AOR) and 95% confidence interval (CI). Statistical significance was declared at a P-value less than 0.05.
Result
The mean age of the participants was 36.88 (±7.29) years. Slightly less than one-third (60, 31.4%) of the women came back for follow-up rescreening within 3 years. Those women who were educated [AOR = 2.2, 95% CI: 1.03-4.68] and treated by Cryotherapy [AOR = 2.4, 95% CI: 1.1-5.4] were more likely to come back for rescreening compared to those who were uneducated and treated by thermal ablation, respectively.
Conclusion
Follow-up rescreening for cervical pre-cancer remains low. Women’s educational status and treatment modality affect the follow-up rescreening. Proper counselling on post-treatment follow-up and available screening and treatment options is very crucial to improve adherence to protocol. A qualitative study is warranted to identify the challenges of follow-up rescreening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, School of Health Sciences, Madda Walabu University, Shashemene, Oromia, Ethiopia.
- Faculty of Health, Medicine and Life Sciences, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands.
ORCID-Profile: Bikila Lencha, Mark Spigt
Zitieren
APA
Lencha, B., Geda, B., Ahmed, K., Kapps, L., & Spigt, M. (2026). Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia. The Oncologist, 31(7). https://doi.org/10.1093/oncolo/oyag237
Vancouver
Lencha B, Geda B, Ahmed K, Kapps L, Spigt M. Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia. The Oncologist. 2026;31(7). doi:10.1093/oncolo/oyag237
BibTeX
@article{Lencha2026,
author = {Lencha, Bikila and Geda, Biftu and Ahmed, Kemal and Kapps, Lara and Spigt, Mark},
title = {Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {7},
doi = {10.1093/oncolo/oyag237}
}
EUVIMED